SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-031435
Filing Date
2024-03-14
Accepted
2024-03-14 16:00:31
Documents
63
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K evok-20231231.htm   iXBRL 10-K 1806494
2 EX-10.11 evok-ex10_11.htm EX-10.11 581992
3 EX-23.1 evok-ex23_1.htm EX-23.1 5787
4 EX-31.1 evok-ex31_1.htm EX-31.1 13969
5 EX-31.2 evok-ex31_2.htm EX-31.2 14255
6 EX-32.1 evok-ex32_1.htm EX-32.1 9200
7 EX-32.2 evok-ex32_2.htm EX-32.2 8833
8 EX-97 evok-ex97.htm EX-97 34620
9 GRAPHIC img215285054_0.jpg GRAPHIC 24883
10 GRAPHIC img215285054_1.jpg GRAPHIC 194336
  Complete submission text file 0000950170-24-031435.txt   7509852

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT evok-20231231.xsd EX-101.SCH 1048860
65 EXTRACTED XBRL INSTANCE DOCUMENT evok-20231231_htm.xml XML 718080
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36075 | Film No.: 24749608
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)